It belongs to the family of growth hormone releasing peptides that stimulate the pituitary gland and brain to produce and release more natural growth hormone
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." December 11, 2025
Further analyses revealed that retatrutide led to complete resolution of excess liver fat in approximately 80% of participants with hepatic steatosis after 24 weeks, increasing to about 90%
Ozempic can cause dyspepsia (upset stomach) or a change in how food tastes (some report an odd aftertaste or reduced appetite, which is partly the goal)
Zepbound Results (SURMOUNT-1 Trial) The SURMOUNT-1 trial studied 2,539 adults with obesity or overweight (without diabetes) over 72 weeks